1/259
A comprehensive collection of 250 practice flashcards for Pathophysiology Exam Four covering burns and inhalation injury, shock states and SIRS/MODS, chronic neurodegenerative disorders, stroke, head trauma and intracranial pressure, spinal cord injuries, and adaptive immunity, autoimmunity, and HIV.
Superficial (first-degree) burn
A burn involving the epidermis only; characterized by red or pink, dry, painful, and tender skin that blanches with pressure, lacks blisters, and heals within days without scarring.
Superficial partial-thickness (second-degree) burn
A burn extending through the epidermis into the superficial dermis; characterized by pink or red, moist, shiny, blistered, briskly blanching skin that is extremely painful and typically heals in approximately 1–3weeks.
Deep partial-thickness (second-degree) burn
A burn extending deeper into the dermis; appears mottled red-and-white or waxy, is relatively dry with fewer blisters, exhibits sluggish or absent blanching, has reduced sensation to light touch, and carries a high risk of scarring and contractures.
Full-thickness (third-degree) burn
A burn destroying the entire epidermis and dermis that may extend into subcutaneous fat; appears white, waxy, brown, black, leathery, or charred, is dry and nonblanching, and is centrally insensate due to destroyed nerve endings.
Fourth-degree burn
A burn that extends completely through the skin layers into underlying subcutaneous fat, muscle, fascia, tendon, or bone, appearing charred or deeply destroyed and often requiring amputation or complex reconstruction.
Total body surface area (TBSA) fluid calculation rule for superficial burns
Superficial (first-degree) burns are strictly excluded from TBSA percentage calculations when determining fluid resuscitation volumes for major burns.
Upper airway thermal injury
Thermal damage predominantly affecting the structures above the vocal cords; causes rapid mucosal edema that can progress over hours to complete mechanical airway obstruction.
Lower airway chemical injury
Direct chemical and smoke irritation to subglottic bronchi and alveoli that triggers bronchospasm, mucosal sloughing, inflammation, thick secretions, atelectasis, and potential delayed ARDS.
Airway casts
Aggregates of sloughed respiratory epithelium, cellular debris, mucus, and inflammatory exudate that obstruct tracheobronchial lumens following lower airway inhalation injury.
Carbon monoxide toxicity in inhalation injury
A condition where carbon monoxide binds hemoglobin with an affinity much greater than oxygen, causing impaired tissue oxygen delivery while pulse oximetry displays falsely reassuring normal saturation levels.
Co-oximetry / carboxyhemoglobin level
The definitive diagnostic blood test used to detect carbon monoxide poisoning and evaluate true carboxyhemoglobin percentage, which standard pulse oximetry cannot differentiate from oxyhemoglobin.
Cyanide toxicity in burn injury
Mitochondrial toxicity caused by inhalation of combustion byproducts in enclosed-space fires that halts cellular aerobic respiration, leading to profound lactic acidosis, seizures, and cardiovascular collapse.
Carbonaceous sputum
Soot-tinged or black-streaked bronchial secretions; a hallmark physical finding indicating smoke inhalation and potential lower airway injury.
Stridor in burn patients
A high-pitched inspiratory sound indicating critical upper airway narrowing and laryngeal edema that warrants immediate endotracheal intubation.
Early endotracheal intubation in inhalation trauma
The proactive clinical priority of securing the airway before progressive pharyngeal and laryngeal edema renders emergency intubation technically impossible.
Thermal burn cooling guideline
The practice of halting the burning process by applying cool running water to the wound while strictly avoiding ice, which can cause vasoconstriction and deepen tissue ischemia.
Hypothermia prevention in burn care
The critical measure of covering burned patients with clean, dry materials and maintaining ambient warmth to prevent rapid core heat loss resulting from compromised skin integrity.
Lactated Ringer's solution in burn shock
The standard isotonic crystalloid solution utilized for major burn fluid resuscitation to replace intravascular volume and mitigate metabolic acidosis without causing hyperchloremia.
Adult burn resuscitation urine output target
A minimum hourly urine output benchmark of at least 0.5mL/kg/hr (typically about 30–50mL/hr) used to titrate crystalloid infusion rates in adult thermal burns.
Electrical burn urine output target
A higher hourly urine output resuscitation target required to maintain renal tubular flushing and prevent acute tubular necrosis secondary to heavy myoglobin and hemoglobin pigment excretion.
Intravenous opioids in acute major burns
The preferred route and medication class for acute severe burn pain management, avoiding intramuscular or subcutaneous routes due to erratic absorption during hypoperfusion and edema.
Hypermetabolic nutritional support in burns
Early initiation of high-calorie, high-protein enteral nutrition to offset profound catabolism, preserve lean muscle mass, prevent stress ulceration, and support wound healing.
Contracture prevention in burn management
The strategic use of anti-contracture positioning, splinting, and range-of-motion exercises to maintain joint mobility as healing burn tissue contracts.
Burn shock
A combined hypovolemic and distributive shock state driven by widespread capillary leak, loss of plasma proteins into the interstitium, massive edema, and severe circulating hypovolemia.
Acute kidney injury (AKI) in burn injury
Renal failure resulting from severe prerenal hypoperfusion, extensive circulating inflammatory mediators, and tubular occlusion by myoglobin from deep tissue destruction.
Myoglobinuria in deep burn trauma
The release of muscle breakdown pigments into the circulation following electrical or deep muscle burns, causing dark red-brown urine and direct tubular cytotoxicity.
Early post-burn hyperkalemia
An acute elevation in serum potassium resulting from massive thermal cytolysis and cellular rupture that releases intracellular potassium into the extracellular space.
Late post-burn hypokalemia
A subsequent drop in serum potassium occurring days after a burn due to extensive fluid shifting, potassium excretion from diuresis, and wound exudate losses.
Escharotomy
A surgical incision made through inelastic, full-thickness burn eschar to relieve internal tissue compartment pressure and restore circulation or ventilation without excising the eschar itself.
Extremity escharotomy indications
Circumferential extremity full-thickness burns exhibiting progressive neurovascular compromise, including severe tightness, paresthesia, pallor, prolonged capillary refill, and loss of Doppler pulses.
Chest escharotomy indication
Circumferential full-thickness chest burns causing severe restriction of thoracic excursion, hypoventilation, elevated airway pressures, and hypoxemia.
Escharotomy versus fasciotomy
An escharotomy incises only through the burned dermis and eschar, whereas a fasciotomy extends deeper through the investing muscle fascia to treat true subfascial compartment syndrome.
Hypovolemic shock mechanism
A critical reduction in intravascular circulating volume that decreases venous return (preload), reduces stroke volume and cardiac output, and leads to generalized tissue hypoperfusion.
Etiologies of hypovolemic shock
Hemorrhage, profound dehydration, severe vomiting or diarrhea, massive plasma exudation from burns, and extensive third-space fluid shifting.
Clinical manifestations of hypovolemic shock
Tachycardia, delayed hypotension, weak and thready pulses, cool clammy pale skin, flat neck veins, oliguria, thirst, delayed capillary refill, and altered sensorium.
Narrow pulse pressure in hypovolemic shock
A decreased difference between systolic and diastolic blood pressure resulting from reduced stroke volume alongside sympathetic compensatory vasoconstriction that elevates diastolic pressure.
Fluid resuscitation in hypovolemic shock
Rapid infusion of isotonic crystalloids via large-bore intravenous access for volume loss, complemented by packed red blood cells and blood products when hemorrhage is present.
Septic shock mechanism
A dysregulated host response to infection causing systemic endothelial activation, widespread vasodilation, increased capillary permeability, microvascular thrombosis, and maldistributed blood flow.
Common infectious foci in septic shock
Pneumonia and lower respiratory tract infections, urinary tract infections, intra-abdominal infections, and skin, soft tissue, or intravascular catheter infections.
Early ('warm') septic shock presentation
The hyperdynamic distributive phase of sepsis characterized by fever, tachycardia, tachypnea, warm or flushed skin, and bounding peripheral pulses.
Late ('cold') septic shock presentation
The hypodynamic phase of septic shock characterized by refractory hypotension, cool, pale, or mottled extremities, weak pulses, oliguria, lethargy, and multisystem organ failure.
Blood culture timing in suspected septic shock
Diagnostic blood cultures must be collected promptly prior to initiating antimicrobials without causing significant delay in the rapid administration of broad-spectrum antibiotics.
Norepinephrine in septic shock
The first-choice vasopressor utilized to restore vascular tone and raise systemic vascular resistance in fluid-refractory septic shock.
Mean Arterial Pressure (MAP) target in septic shock
A clinical resuscitation target of ≥65mmHg maintained via fluids and vasopressors to ensure adequate vital organ tissue perfusion.
Cardiogenic shock mechanism
Primary myocardial pump failure resulting in inadequate cardiac output and systemic hypoperfusion despite an adequate or elevated intravascular circulating volume.
Etiologies of cardiogenic shock
Extensive acute myocardial infarction, end-stage heart failure, acute cardiomyopathy, severe dysrhythmias, and acute mechanical or valvular disruptions.
Clinical manifestations of cardiogenic shock
Hypotension, tachycardia, cool and clammy skin, weak pulses, pulmonary crackles, dyspnea, jugular venous distention (JVD), chest pain, and oliguria.
Pulmonary congestion in cardiogenic shock
Fluid transudation into the alveoli and pulmonary crackles caused by elevated left ventricular end-diastolic pressure and backward hydrostatic venous engorgement.
Fluid administration caution in cardiogenic shock
The clinical principle that aggressive fluid boluses must be avoided because fluid overload worsens ventricular wall stress, elevates filling pressures, and intensifies pulmonary edema.
Neurogenic shock mechanism
A distributive shock caused by the disruption of descending sympathetic outflow from the spinal cord, resulting in widespread arterial vasodilation, venous pooling, and unopposed parasympathetic vagal activity.
Etiology of neurogenic shock
Traumatic injury to the cervical or high thoracic spinal cord, typically at or above the level of T6.
Classic clinical triad of neurogenic shock
The distinct presentation consisting of persistent hypotension, bradycardia, and warm, dry, flushed skin below the level of the injury.
Unopposed vagal tone in neurogenic shock
Loss of sympathetic cardiac accelerator nerve stimulation leaving the intact cranial parasympathetic vagus nerve unchecked, resulting in inappropriate bradycardia.
Atropine in neurogenic shock
An anticholinergic agent administered intravenously to block parasympathetic vagal stimulation and treat clinically significant bradycardia.
Temperature dysregulation in neurogenic shock
Poikilothermia caused by loss of sympathetic vasomotor control and sweat gland regulation, rendering the client susceptible to rapid hypothermia matching the ambient room environment.
Anaphylactic shock mechanism
A severe, life-threatening type I hypersensitivity reaction wherein antigen cross-linking of IgE on mast cells and basophils triggers massive release of histamine and inflammatory mediators, causing vasodilation, capillary leak, and bronchospasm.
Common triggers of anaphylactic shock
Medications (such as antibiotics), foods (including peanuts and shellfish), insect stings, and natural rubber latex.
Clinical manifestations of anaphylaxis
Sudden urticaria, pruritus, angioedema of the lips and tongue, stridor, wheezing, dyspnea, abdominal cramping, vomiting, and profound circulatory collapse.
First-line intervention for anaphylactic shock
Immediate administration of intramuscular epinephrine, which must never be delayed for secondary adjunct medications.
Intramuscular epinephrine injection site
The anterolateral aspect of the mid-outer thigh (vastus lateralis), which provides the most rapid and reliable systemic vascular absorption.
Adjunct medications in anaphylaxis
Secondary therapies including intravenous antihistamines, inhaled beta-agonists, and systemic corticosteroids, which do not substitute for emergency epinephrine administration.
Hemodynamic distinction: Hypovolemic vs Septic shock
Hypovolemic shock features actual circulating fluid loss with cold/clammy skin, whereas early septic shock features normal/high total body fluid with vasodilation and warm/flushed skin.
Hemodynamic distinction: Cardiogenic vs Hypovolemic shock
Cardiogenic shock exhibits pulmonary crackles and jugular venous distention from elevated filling pressures, whereas hypovolemic shock presents with clear lungs and flat neck veins.
Hemodynamic distinction: Neurogenic vs Hypovolemic shock
Neurogenic shock uniquely presents with bradycardia and warm, dry skin, whereas hypovolemic shock characteristically presents with compensatory tachycardia and cool, clammy skin.
Prerenal azotemia in shock
A reversible elevation of BUN and serum creatinine accompanied by concentrated urine and oliguria, driven directly by renal hypoperfusion and decreased glomerular filtration.
Acute tubular necrosis (ATN) in prolonged shock
Intrinsic renal parenchymal injury resulting from sustained ischemic hypoperfusion, leading to epithelial cell sloughing and persistent acute kidney injury.
Ischemic hepatitis ('shock liver')
Centrilobular hepatic necrosis induced by profound systemic hypotension and hypoperfusion, resulting in marked, rapid surges in serum transaminases.
Laboratory profile of ischemic hepatitis
Steep, marked elevations in AST and ALT, followed by rising serum bilirubin levels and potential prolongation of PT/INR reflecting compromised hepatic synthetic function.
Serum lactate elevation in shock states
An accumulation of lactic acid in the blood reflecting widespread anaerobic cellular metabolism and systemic tissue hypoperfusion.
Systemic Inflammatory Response Syndrome (SIRS)
A widespread, dysregulated systemic inflammatory response triggered by infectious or noninfectious insults that causes endothelial activation, vasodilation, and microvascular permeability.
Noninfectious etiologies of SIRS
Major traumatic injuries, severe burns, acute pancreatitis, extensive surgical interventions, and severe tissue ischemia or reperfusion injury.
SIRS temperature criteria
Core body temperature exceeding >38∘C (100.4∘F) or dropping below <36∘C (96.8∘F).
SIRS heart rate criterion
Sustained tachycardia with a heart rate greater than >90/min.
SIRS respiratory criteria
Tachypnea with a respiratory rate exceeding >20/min or arterial hypocapnia evidenced by PaCO2<32mmHg.
SIRS white blood cell criteria
A white blood cell count exceeding >12,000/mm3, falling below <4,000/mm3, or presenting with greater than >10% immature band forms.
Multiple Organ Dysfunction Syndrome (MODS)
The progressive, insidious dysfunction of two or more distinct organ systems in an acutely ill client such that systemic homeostasis cannot be maintained without clinical intervention.
Blood pressure limitation in early shock detection
A normal systolic blood pressure does not rule out early compensated shock, as sympathetic compensatory mechanisms maintain pressure despite critical tissue hypoperfusion.
Shock laboratory triad of worsening perfusion
A clinical monitoring pattern characterized by a rising serum lactate, decreasing hourly urine output, and rising serum creatinine.
Multiple sclerosis (MS) pathophysiology
A chronic autoimmune inflammatory disease of the central nervous system wherein an immune attack damages myelin sheaths and oligodendrocytes in the brain, spinal cord, and optic nerves.
Oligodendrocytes in multiple sclerosis
The specialized myelin-producing glial cells of the central nervous system that are selectively targeted and destroyed by autoimmune inflammation in MS.
Sclerotic plaques in MS
Patches of chronic glial scarring and demyelination dispersed across the white matter of the brain and spinal cord that disrupt normal axonal electrical conduction.
Relapsing-remitting multiple sclerosis
The most common disease course of MS, characterized by clearly defined acute inflammatory flare-ups of neurological dysfunction followed by periods of partial or complete recovery.
Uhthoff phenomenon
A transient, reversible worsening of preexisting neurological symptoms in multiple sclerosis triggered by increased core body temperature from fever, exercise, warm baths, or heat exposure.
Optic neuritis in MS
Inflammatory demyelination of the optic nerve presenting acutely with painful, unilateral loss of vision, impaired color perception, and visual blurring.
Clinical manifestations of multiple sclerosis
Profound fatigue, diplopia, nystagmus, focal numbness and paresthesias, spasticity, ataxia, gait instability, neurogenic bladder dysfunction, and cognitive changes.
Acute multiple sclerosis exacerbation (relapse)
New or worsening neurological deficits lasting at least 24hours in the absence of fever or infection, typically separated from previous attacks by at least ≥30days.
MS pseudoexacerbation triggers
Transient worsening of chronic MS deficits driven by systemic infections (such as UTIs), physiological fever, elevated ambient heat, or severe exhaustion without active demyelinating lesion growth.
Parkinson disease pathophysiology
A progressive neurodegenerative movement disorder caused by the loss of dopamine-producing neurons within the substantia nigra pars compacta, leading to dopamine depletion in the basal ganglia.
Substantia nigra pars compacta
The midbrain nucleus responsible for synthesizing dopamine and projecting it to the striatum to facilitate smooth, coordinated voluntary motor control.
Lewy bodies
Abnormal intracellular eosinophilic protein aggregates found in degenerating dopaminergic neurons of clients with Parkinson disease.
Alpha-synuclein
The primary misfolded protein constituent that aggregates inside neurons to form pathological Lewy bodies in Parkinson disease.
Dopamine-acetylcholine imbalance in Parkinson disease
A neurochemical disruption wherein the loss of inhibitory dopaminergic signaling leads to relative overactivity of excitatory cholinergic transmission in the basal ganglia.
'TRAP' tetrad in Parkinson disease
The four cardinal motor features of Parkinson disease: resting Tremor, cogwheel Rigidity, Akinesia or bradykinesia, and Postural instability.
Resting tremor ('pill-rolling')
A rhythmic 4–6Hz involuntary shaking of the hands or fingers that occurs predominantly when the limb is supported at rest and diminishes during purposeful movement.
Cogwheel rigidity
A jerky, ratchet-like resistance perceived during passive range of motion of an extremity in Parkinson disease, resulting from a combination of muscle rigidity and resting tremor.
Bradykinesia and akinesia
Marked slowness in executing voluntary motor actions and difficulty initiating spontaneous movements, characteristic of Parkinson disease.
Festinating gait
A characteristic stooped, shuffling Parkinsonian gait featuring short, hurried steps with involuntary acceleration as the client attempts to keep their feet under their center of gravity.
Masked facies
A flattened, emotionless facial expression with reduced spontaneous blinking caused by bradykinesia and rigidity of facial musculature in Parkinson disease.
Micrographia
A progressive shrinkage in handwriting size across a line of script, serving as a classic clinical manifestation of bradykinesia in Parkinson disease.
Amyotrophic lateral sclerosis (ALS) pathophysiology
A fatal, progressive neurodegenerative disease characterized by the simultaneous degeneration of upper motor neurons in the cerebral cortex and lower motor neurons in the brainstem and spinal cord.